Literature DB >> 16133661

Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II.

Tomomi Kato1,2, Zenichiro Kato3, Izumi Kuratsubo3, Noboru Tanaka4, Tabito Ishigami4, Jun-Ichi Kajihara4, Kazuko Sukegawa-Hayasaka3, Koji Orii3, Koji Isogai3, Toshiyuki Fukao3, Nobuyuki Shimozawa5, Tadao Orii6, Naomi Kondo3, Yasuyuki Suzuki3,7.   

Abstract

We investigated mutations of the iduronate-2-sulfatase (I2S) gene and structural characteristics of I2S to clarify genotype/phenotype relationships in 18 Japanese patients with mucopolysaccharidosis type II. The I2S gene was analyzed in five patients with a severe phenotype and in 13 patients with an attenuated phenotype. The tertiary structural model of the human I2S was constructed by homology modeling using the arylsulfatase structure as a template. We identified four missense mutations and a nonsense mutation in the severe phenotype; four missense, two nonsense, three frame shifts, and one each of splice and amino acid deletion in the attenuated phenotype. Seven of them (L73del, Q75X, G140R, C171R, V401 fs, C422 fs, and H441 fs) were novel mutations. Structural analysis indicated that the residues of the mutations found in the severe phenotype would have direct interactions with the active site residues or should break the hydrophobic core domain of I2S, whereas residues of the missense mutations found in the attenuated phenotype were located in the peripheral region. In addition, effects by deletion or frameshift mutations could also be interpreted by the structure. Structural analysis of mutant proteins would help in understanding the genotype/phenotype relationships of Hunter disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133661     DOI: 10.1007/s10038-005-0266-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  23 in total

1.  Mutation analysis of iduronate-2-sulphatase gene in 24 patients with Hunter syndrome: characterisation of 6 novel mutations. Mutation in brief no. 249. Online.

Authors:  C Hartog; A Fryer; M Upadhyaya
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

2.  Mutations in the iduronate-2-sulfatase gene in 12 Spanish patients with Hunter disease.

Authors:  L Gort; M J Coll; A Chabás
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

3.  Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.

Authors:  K Sukegawa; H Nakamura; Z Kato; S Tomatsu; A M Montaño; T Fukao; G Toietta; P Tortora; T Orii; N Kondo
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

4.  Spinal muscular atrophy: survival pattern and functional status.

Authors:  Brian H Y Chung; Virginia C N Wong; Patrick Ip
Journal:  Pediatrics       Date:  2004-10-18       Impact factor: 7.124

5.  A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).

Authors:  Y V Voznyi; J L Keulemans; O P van Diggelen
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

6.  Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene.

Authors:  M Rathmann; S Bunge; M Beck; H Kresse; A Tylki-Szymanska; A Gal
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease).

Authors:  E Vafiadaki; A Cooper; L E Heptinstall; C E Hatton; M Thornley; J E Wraith
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

8.  Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.

Authors:  S Karsten; E Voskoboeva; S Tishkanina; U Pettersson; X Krasnopolskaja; M L Bondeson
Journal:  Hum Genet       Date:  1998-12       Impact factor: 4.132

9.  Mucopolysaccharidosis type II (Hunter disease): 13 gene mutations in 52 Japanese patients and carrier detection in four families.

Authors:  Y Yamada; S Tomatsu; K Sukegawa; Y Suzuki; N Kondo; J J Hopwood; T Orii
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

10.  Detection of four novel mutations in the iduronate-2-sulfatase gene. Mutations in brief no. 123. Online.

Authors:  N Balzano; G R Villani; M Grosso; P Izzo; P Di Natale
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

View more
  14 in total

1.  Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.

Authors:  Johanna Galvis; Jannet González; Alfredo Uribe; Harvy Velasco
Journal:  JIMD Rep       Date:  2015-02-15

2.  Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis.

Authors:  Paulina Nieves Cobos; Cordula Steglich; René Santer; Zoltan Lukacs; Andreas Gal
Journal:  JIMD Rep       Date:  2014-05-06

3.  Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis.

Authors:  K Sukegawa-Hayasaka; Z Kato; H Nakamura; S Tomatsu; T Fukao; K Kuwata; T Orii; N Kondo
Journal:  J Inherit Metab Dis       Date:  2006-11-07       Impact factor: 4.982

4.  Convergent molecular mechanisms underlying cognitive impairment in mucopolysaccharidosis type II.

Authors:  Thiago Corrêa; Fabiano Poswar; Cíntia B Santos-Rebouças
Journal:  Metab Brain Dis       Date:  2021-11-19       Impact factor: 3.655

5.  SAAMP 2.0: An algorithm to predict genotype-phenotype correlation of lysosomal storage diseases.

Authors:  L Ou; M J Przybilla; C B Whitley
Journal:  Clin Genet       Date:  2018-03-05       Impact factor: 4.438

6.  Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome.

Authors:  S Keeratichamroen; J R Ketudat Cairns; D Wattanasirichaigoon; P Wasant; L Ngiwsara; P Suwannarat; S Pangkanon; J Kuptanon; P Tanpaiboon; T Rujirawat; S Liammongkolkul; J Svasti
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

7.  Analysis of the IDS gene in 38 patients with Hunter syndrome: the c.879G>A (p.Gln293Gln) synonymous variation in a female create exonic splicing.

Authors:  Huiwen Zhang; Jing Li; Xinshun Zhang; Yu Wang; Wenjuan Qiu; Jun Ye; Lianshu Han; Xiaolan Gao; Xuefan Gu
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

8.  Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.

Authors:  Mary Anne D Chiong; Daffodil M Canson; Mary Ann R Abacan; Melissa Mae P Baluyot; Cynthia P Cordero; Catherine Lynn T Silao
Journal:  Orphanet J Rare Dis       Date:  2017-01-11       Impact factor: 4.123

Review 9.  Zebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use.

Authors:  Hung-Chieh Lee; Cheng-Yung Lin; Huai-Jen Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24

10.  Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases.

Authors:  Seiji Saito; Kazuki Ohno; Torayuki Okuyama; Hitoshi Sakuraba
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.